| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIP | Common Stock | Sale | -$1.71M | -27.9K | -2.26% | $61.15 | 1.2M | Aug 14, 2023 | Held by Esjay LLC | F1, F2, F3 |
| transaction | ANIP | Common Stock | Sale | -$1.36M | -22.1K | -1.84% | $61.60 | 1.18M | Aug 15, 2023 | Held by Esjay LLC | F1, F3, F4 |
| holding | ANIP | Common Stock | 47.4K | Aug 14, 2023 | Direct | ||||||
| holding | ANIP | Common Stock | 5K | Aug 14, 2023 | Held by SS Pharma LLC | F5 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.12 to $62.58, inclusive. |
| F3 | The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.81 to $62.59, inclusive. |
| F5 | The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC. |